This country profile provides an overview of São Tomé and Príncipe’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage decreased from 81% in 2018 to 72% in 2019.
São Tomé and Príncipe does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 89% in 2018 to 65% in 2019.
Treatment coverage decreased from 98% in 2018 to 61% in 2019.
São Tomé and Príncipe does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in São Tomé and Príncipe.